- Home
- RR vs LYEL Comparison
RR vs LYEL Comparison
Compare RR & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RR
- LYEL
- Stock Information
- Founded
- RR 2016
- LYEL 2018
- Country
- RR United States
- LYEL United States
- Employees
- RR N/A
- LYEL N/A
- Industry
- RR
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- RR
- LYEL Health Care
- Exchange
- RR Nasdaq
- LYEL Nasdaq
- Market Cap
- RR 235.3M
- LYEL 207.7M
- IPO Year
- RR 2023
- LYEL 2021
- Fundamental
- Price
- RR $2.31
- LYEL $0.44
- Analyst Decision
- RR Strong Buy
- LYEL Sell
- Analyst Count
- RR 1
- LYEL 2
- Target Price
- RR $3.50
- LYEL $1.00
- AVG Volume (30 Days)
- RR 11.7M
- LYEL 627.4K
- Earning Date
- RR 05-14-2025
- LYEL 05-13-2025
- Dividend Yield
- RR N/A
- LYEL N/A
- EPS Growth
- RR N/A
- LYEL N/A
- EPS
- RR N/A
- LYEL N/A
- Revenue
- RR $4,392,000.00
- LYEL $65,000.00
- Revenue This Year
- RR $76.49
- LYEL N/A
- Revenue Next Year
- RR $144.81
- LYEL N/A
- P/E Ratio
- RR N/A
- LYEL N/A
- Revenue Growth
- RR N/A
- LYEL N/A
- 52 Week Low
- RR $0.30
- LYEL $0.39
- 52 Week High
- RR $5.20
- LYEL $2.80
- Technical
- Relative Strength Index (RSI)
- RR 51.05
- LYEL 51.63
- Support Level
- RR $2.12
- LYEL $0.39
- Resistance Level
- RR $2.90
- LYEL $0.43
- Average True Range (ATR)
- RR 0.27
- LYEL 0.03
- MACD
- RR 0.01
- LYEL 0.00
- Stochastic Oscillator
- RR 31.40
- LYEL 83.39
About RR Richtech Robotics Inc. Class B
Richtech Robotics Inc is a developer of new robotic technologies focused on transforming labor-intensive services in hospitality and other sectors currently experiencing unprecedented labor shortages. The company designs, manufacture and sells robots to restaurants, hotels, senior living centers, casinos, factories, movie theaters and other businesses. Its robots perform a variety of services including restaurant running and bussing, hotel room service delivery, floor scrubbing and vacuuming, and beverage and food preparation. The company designs its robots to be friendly, customizable to client environments, and extremely reliable.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.